MedTrace Logo

Topical 0.4% Ketorolac and Vitreoretinal Surgery

NCT00576329 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2014-05-14

No results posted yet for this study

Summary

To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Conditions

  • Surgery

Interventions

DRUG

Ketorolac

Topical use before surgery

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Stephen J Kim, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576329 on ClinicalTrials.gov